Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Scholz

Showing results (11-20 of 311) with videos related to

Pageof 32
Sort By:
BMC Bioinformatics|June 27, 2014
Ycasd - a tool for capturing and scaling data from graphical representationsArnd Gross, Sibylle Schirm, Markus Scholz
Bulletin of Mathematical Biology|December 17, 2013
Modelling lymphoma therapy and outcomeKatja Roesch, Dirk Hasenclever, Markus Scholz
Heliyon|July 24, 2023
Individual modelling of haematotoxicity with NARX neural networks: A knowledge transfer approachMarie Steinacker, Yuri Kheifetz, Markus Scholz
Viruses|July 27, 2022
On the Parametrization of Epidemiologic Models-Lessons from Modelling COVID-19 EpidemicYuri Kheifetz, Holger Kirsten, Markus Scholz
Leukemia & Lymphoma|December 16, 2015
Modeling combined chemo- and immunotherapy of high-grade non-Hodgkin lymphomaKatja Rösch, Markus Scholz, Dirk Hasenclever
Journal of Synchrotron Radiation|July 2, 2021
The influence of strain on image reconstruction in Bragg coherent X-ray diffraction imaging and ptychographyChan Kim, Markus Scholz, Anders Madsen
British Journal of Haematology|February 21, 2006
Model-based design of chemotherapeutic regimens that account for heterogeneity in leucopoeniaMarkus Scholz, Christoph Engel, Markus Loeffler, et al.
Blood|July 1, 2004
A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapyChristoph Engel, Markus Scholz, Markus Loeffler
Journal of Theoretical Biology|January 20, 2010
A biomathematical model of human thrombopoiesis under chemotherapyMarkus Scholz, Arnd Gross, Markus Loeffler
BMC Genetics|December 8, 2017
On the impact of relatedness on SNP association analysisArnd Gross, Anke Tönjes, Markus Scholz
Pageof 32

Showing results (11-20 of 311) with videos related to

Sort By:
Pageof 32
BMC Bioinformatics|June 27, 2014
Ycasd - a tool for capturing and scaling data from graphical representationsArnd Gross, Sibylle Schirm, Markus Scholz
Bulletin of Mathematical Biology|December 17, 2013
Modelling lymphoma therapy and outcomeKatja Roesch, Dirk Hasenclever, Markus Scholz
Heliyon|July 24, 2023
Individual modelling of haematotoxicity with NARX neural networks: A knowledge transfer approachMarie Steinacker, Yuri Kheifetz, Markus Scholz
Viruses|July 27, 2022
On the Parametrization of Epidemiologic Models-Lessons from Modelling COVID-19 EpidemicYuri Kheifetz, Holger Kirsten, Markus Scholz
Leukemia & Lymphoma|December 16, 2015
Modeling combined chemo- and immunotherapy of high-grade non-Hodgkin lymphomaKatja Rösch, Markus Scholz, Dirk Hasenclever
Journal of Synchrotron Radiation|July 2, 2021
The influence of strain on image reconstruction in Bragg coherent X-ray diffraction imaging and ptychographyChan Kim, Markus Scholz, Anders Madsen
British Journal of Haematology|February 21, 2006
Model-based design of chemotherapeutic regimens that account for heterogeneity in leucopoeniaMarkus Scholz, Christoph Engel, Markus Loeffler, et al.
Blood|July 1, 2004
A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapyChristoph Engel, Markus Scholz, Markus Loeffler
Journal of Theoretical Biology|January 20, 2010
A biomathematical model of human thrombopoiesis under chemotherapyMarkus Scholz, Arnd Gross, Markus Loeffler
BMC Genetics|December 8, 2017
On the impact of relatedness on SNP association analysisArnd Gross, Anke Tönjes, Markus Scholz
Pageof 32